Downstream Processing

Increasing efficiency and quality through effective application of advanced technologies is becoming predominant.

The Purolite AP+50 affinity chromatography resin has a 50-micron bead size that offers dynamic binding capacity of the AP resin platform while providing durability for monoclonal antibody capture.

A continuous biomanufacturing platform can process higher/lower quantities of a drug as needed and allow manufacturers to respond to changing markets.

Although automation is increasingly adopted in biomanufacturing, challenges remain in implementing it at the cell harvesting step.

Webinar Date/Time: Tue, Jun 3, 2025 2:00 PM EDT

Webinar Date/Time: Tue, May 20, 2025 2:00 PM EDT

The benefits include reduced contamination risks, simplified validation processes, and streamlined operations.

Many factors must be considered to overcome the challenges associated with viral clearance.

Webinar Date/Time: Thu, Dec 12, 2024 11:00 AM EST

Webinar Date/Time: Thu, Nov 7, 2024 11:00 AM EDT

Webinar Date/Time: Thu, Oct 31, 2024 11:00 AM EDT

Webinar Date/Time: Wed, Oct 16, 2024 11:00 AM EDT

Webinar Date/Time: Tue, Oct 8, 2024 11:00 AM EDT

Collaboration between technology providers and biopharma manufacturers are enabling both evolutionary and novel developments.

Downstream processes may be streamlined by using automation.

Automation technologies used in the development and manufacture of biopharmaceuticals continue to evolve, providing the potential for reduced costs and time.

Freudenberg Medical now offers custom single-use assemblies to expand its offerings in silicone extrusion and molding for biopharma applications.

Webinar Date/Time: Wed, Jul 24, 2024 12:00 PM EDT

Ecolab Life Sciences and Repligen introduce DurA Cycle, a new affinity resin for large-scale biologics manufacturing.

The biopharma industry is looking at continuous chromatography for sensitive molecules.

Webinar Date/Time: Wed, Jun 19, 2024 11:00 AM EDT

Webinar Date/Time: Thu, Jun 13, 2024 11:00 AM EDT

Studies conducted by a team at Oxford Biomedica demonstrated that HIC can be used to effectively separate non-deamidated capsids from deamidated capsids.

Experiments conducted by the downstream technology team at Spark Therapeutics involving metal ion-containing additives showed improved capsid clearance in AAV production.

Webinar Date/Time: Tue, May 14, 2024 1:00 PM EDT